|
EP1289996B1
(en)
|
2000-05-25 |
2005-04-06 |
Targacept, Inc. |
Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands
|
|
US6624167B1
(en)
|
2000-08-04 |
2003-09-23 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
|
DE60216830T2
(de)
*
|
2001-02-06 |
2007-06-14 |
Pfizer Products Inc., Groton |
Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen
|
|
DE10164139A1
(de)
|
2001-12-27 |
2003-07-10 |
Bayer Ag |
2-Heteroarylcarbonsäureamide
|
|
SE0202430D0
(sv)
*
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
New Compounds
|
|
SE0202465D0
(sv)
*
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
New compounds
|
|
CA2499128C
(en)
|
2002-09-25 |
2012-07-31 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
|
|
JP2006519208A
(ja)
*
|
2003-02-27 |
2006-08-24 |
ニューロサーチ、アクティーゼルスカブ |
新規ジアザビシクロアリール誘導体
|
|
PL1697378T3
(pl)
|
2003-12-22 |
2008-04-30 |
Memory Pharm Corp |
Indole, 1h-indazole, 1,2-benzoizoksazole i 1,2-benzoizotiazole oraz ich wytwarzanie i zastosowania
|
|
TW200529860A
(en)
*
|
2003-12-22 |
2005-09-16 |
Astrazeneca Ab |
Nicotinic acetylcholine receptor ligands
|
|
WO2005061511A1
(en)
*
|
2003-12-22 |
2005-07-07 |
Astrazeneca Ab |
Nicotinic acetylcholine receptor ligands
|
|
AU2005210039B2
(en)
|
2004-02-04 |
2010-09-02 |
Neurosearch A/S |
Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
|
|
WO2005092890A2
(en)
|
2004-03-25 |
2005-10-06 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
|
|
DE602005024677D1
(de)
|
2004-04-22 |
2010-12-23 |
Memory Pharm Corp |
Indole, 1h-indazole, 1,2-benzisoxazole, 1,2-benzoisothiazole, deren herstellung und verwendungen
|
|
RU2386633C2
(ru)
*
|
2004-05-07 |
2010-04-20 |
Мемори Фармасьютиклз Корпорейшн |
1h-индазолы, бензотиазолы, 1, 2-бензоизоксазолы, 1, 2-бензоизотиазолы и хромоны и их получение и применения
|
|
CA2584836A1
(en)
|
2004-10-15 |
2006-04-20 |
Neurosearch A/S |
Novel azabicyclic aryl derivatives and their medical use
|
|
JP2008525464A
(ja)
|
2004-12-22 |
2008-07-17 |
メモリー・ファーマシューティカルズ・コーポレイション |
α−７ニコチン性受容体リガンド並びにその製造及び使用
|
|
US8106066B2
(en)
|
2005-09-23 |
2012-01-31 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
|
|
US20090075983A1
(en)
*
|
2006-02-14 |
2009-03-19 |
Dan Peters |
Novel Diazabicycloalkane Derivatives and Their Medical Use
|
|
JP2007217370A
(ja)
*
|
2006-02-17 |
2007-08-30 |
Nard Inst Ltd |
ポジトロン断層撮影法および該方法に用いるポジトロン放出化合物
|
|
JP2009537598A
(ja)
*
|
2006-05-23 |
2009-10-29 |
ノイロサーチ アクティーゼルスカブ |
新規１，４−ジアザ−ビシクロ［３．２．２］ノナン誘導体及びそれらの医学的使用
|
|
WO2008028903A2
(en)
|
2006-09-04 |
2008-03-13 |
Neurosearch A/S |
Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
|
|
WO2008119710A1
(en)
*
|
2007-03-30 |
2008-10-09 |
Neurosearch A/S |
Two-phase test method for characterizing the effect of a chemical compound on a test animal and maze for carrying out the method
|
|
SA08290475B1
(ar)
*
|
2007-08-02 |
2013-06-22 |
Targacept Inc |
(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
|
|
FR2931677B1
(fr)
*
|
2008-06-02 |
2010-08-20 |
Sanofi Aventis |
Association d'un agoniste partiel des recepteurs nicotiniques et d'un inhibiteur d'acetylcholinesterase, composition la contenant et son utilisation dans le traitement des troubles cognitifs
|
|
FR2931823B1
(fr)
|
2008-06-02 |
2012-08-17 |
Sanofi Aventis |
Sel de fumarate du 1,4-diazabicyclo°3.2.2!nonane-carboxylate de 4-bromophenyle, ses formes cristallines, leur preparation et leur utilisation en therapeutique
|
|
HUE026815T2
(en)
|
2008-11-19 |
2016-07-28 |
Forum Pharmaceuticals Inc |
Treatment of Cognitive Disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
|
|
TW201031664A
(en)
|
2009-01-26 |
2010-09-01 |
Targacept Inc |
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
|
|
AU2010247835A1
(en)
*
|
2009-05-11 |
2011-12-08 |
Envivo Pharmaceuticals, Inc. |
Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors
|
|
TWI519532B
(zh)
|
2010-05-17 |
2016-02-01 |
艾維沃製藥公司 |
（Ｒ）－７－氯－Ｎ－（啶－３－基）苯並［b］噻吩－２－羧醯胺鹽酸鹽單水合物之結晶形體
|
|
LT2685986T
(lt)
*
|
2011-03-18 |
2020-03-10 |
Genzyme Corporation |
Gliukozilceramido sintazės slopiklis
|
|
RU2017136693A
(ru)
|
2012-05-08 |
2019-02-08 |
Форум Фармасьютикалз, Инк. |
Способы поддержания, лечения или улучшения когнитивной функции
|
|
MA37975B2
(fr)
|
2012-09-11 |
2021-03-31 |
Genzyme Corp |
Inhibiteurs de synthase de glucosylcéramide
|
|
CN107188900B
(zh)
*
|
2017-05-27 |
2019-09-06 |
北京师范大学 |
α7烟碱型乙酰胆碱受体的配体化合物及其应用
|
|
PT3920912T
(pt)
|
2019-02-04 |
2025-09-09 |
Genzyme Corp |
Tratamento de ciliopatias usando inibidores da glucosilceramida sintase (gcs)
|
|
IL295255A
(en)
|
2020-02-03 |
2022-10-01 |
Genzyme Corp |
Methods for treating neurological symptoms associated with lysosomal storage diseases
|
|
IL300090A
(en)
|
2020-07-24 |
2023-03-01 |
Genzyme Corp |
Pharmaceutical preparations containing VENGLUSTAT
|